Amount Raised
$25 Million
Round Type
Post-IPO Equity
MedfieldBiotechnologyHealth CareInvestors
Description
Odyssey Therapeutics, Inc. completed a private placement financing, raising $25 million through the sale of 1,388,889 shares at $18.00 per share. The financing was executed in conjunction with the company's initial public offering. TPG LSI Rise Orazio II, L.P., an existing stockholder, was the principal purchaser
Quick answer
Odyssey Therapeutics, Inc. raised $25 Million in a Post-IPO Equity round, dated May 7, 2026. Investors: Oppenheimer And Co. Inc., Wedbush & Co., LLC, Cantor Fitzgerald & Co., TD Securities (USA) LLC, J.P. Morgan Securities LLC and Tpg Lsi Rise Orazio II, L.P. Odyssey Therapeutics, Inc. is based in Medfield, Massachusetts, United States.
- How much did Odyssey Therapeutics, Inc. raise?
- Odyssey Therapeutics, Inc. raised $25 Million in a Post-IPO Equity round on May 7, 2026.
- Who invested in Odyssey Therapeutics, Inc?
- Oppenheimer And Co. Inc., Wedbush & Co., LLC, Cantor Fitzgerald & Co., TD Securities (USA) LLC, J.P. Morgan Securities LLC and Tpg Lsi Rise Orazio II, L.P. are named as investors in this round.
- What does Odyssey Therapeutics, Inc. do?
- Odyssey Therapeutics is a biotechnology company pioneering the efficient development of next generation immunomodulators and oncology medicines.
- Where is Odyssey Therapeutics, Inc. based and how big is it?
- Odyssey Therapeutics, Inc. is based in Medfield, Massachusetts, United States.
Source: Fundz verified event record.
Who else raised in Biotechnology and Health Care around the same time
Companies in the same sectors as Odyssey Therapeutics, Inc. that raised within 45 days of this round, from Fundz verified event records.
- Syntax Bio raised $14M (Series A) on June 21, 2026.
- Houdini Bio raised $2M (Pre-Seed) on June 19, 2026.
- illumicell AI raised $500K (Seed) on June 19, 2026.
- Clair Health raised $12M (Seed) on June 19, 2026.
- Kinomatic raised $4M (Seed) on June 18, 2026.
- RedHill Biopharma Ltd raised $6M (Post-IPO Equity) on June 18, 2026.
Who to call at Odyssey Therapeutics, Inc., and when
A new round usually means Odyssey Therapeutics, Inc. is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Odyssey Therapeutics, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Odyssey Therapeutics, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Odyssey Therapeutics, Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Odyssey Therapeutics, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Odyssey Therapeutics, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.